新型抗糖尿病药物二肽基肽酶Ⅳ抑制剂

被引:17
作者
焦伟杰 [1 ]
朱崇泉 [2 ]
赖宜生 [1 ]
张奕华 [1 ]
曹庆先 [2 ]
机构
[1] 中国药科大学新药研究中心
[2] 江苏省药物研究所
关键词
2型糖尿病; 二肽基肽酶Ⅳ抑制剂; 构效关系;
D O I
暂无
中图分类号
R977.1 [激素类药物];
学科分类号
100710 [药物代谢动力学];
摘要
2型糖尿病严重威胁着人类健康,而现有抗糖尿病药物不能有效阻止糖尿病患者病情恶化。二肽基肽酶Ⅳ抑制剂作为新型抗糖尿病药物越来越引起人们关注。介绍以二肽基肽酶Ⅳ为靶标的药物研究现状,重点探讨不同类型的二肽基肽酶Ⅳ抑制剂的构效关系。
引用
收藏
页码:289 / 296
页数:8
相关论文
共 10 条
[1]
Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV [J].
Kondo, Takashi ;
Sugimoto, Isamu ;
Nekado, Takahiro ;
Ochi, Kenya ;
Ohtani, Tazumi ;
Tajima, Yohei ;
Yamamoto, Susumu ;
Kawabata, Kazuhito ;
Nakai, Hisao ;
Toda, Masaaki .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) :2715-2735
[2]
4-Arylcyclohexylalanine analogs as potent; selective; and orally active inhibitors of dipeptidyl peptidase IV.[J].David E. Kaelin;Abigail L. Smenton;George J. Eiermann;Huaibing He;Barbara Leiting;Kathryn A. Lyons;Reshma A. Patel;Sangita B. Patel;Alexsandr Petrov;Giovanna Scapin;Joseph K. Wu;Nancy A. Thornberry;Ann E. Weber;Joseph L. Duffy.Bioorganic & Medicinal Chemistry Letters.2007, 21
[3]
Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes [J].
Liang, Gui-Bai ;
Qian, Xiaoxia ;
Feng, Dennis ;
Biftu, Tesfaye ;
Eiermann, George ;
He, Hualbing ;
Leiting, Barbara ;
Lyons, Kathy ;
Petrov, Aleksandr ;
Sinha-Roy, Ranabir ;
Zhang, Bei ;
Wu, Joseph ;
Zhang, Xiaoping ;
Thornberry, Nancy A. ;
Weber, Ann E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1903-1907
[4]
Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active site [J].
Sheehan, Scott M. ;
Mest, Hans-Juergen ;
Watson, Brian M. ;
Klimkowski, Valentine J. ;
Timm, David E. ;
Cauvin, Annick ;
Parsons, Stephen H. ;
Shi, Qing ;
Canada, Emily J. ;
Wiley, Michael R. ;
Ruehter, Gerd ;
Evers, Britta ;
Petersen, Soenke ;
Blaszczak, Larry C. ;
Pulley, Shon R. ;
Margolis, Brandon J. ;
Wishart, Graham N. ;
Renson, Beatrice ;
Hankotius, Dirk ;
Mohr, Michael ;
Zechel, Johann-Christian ;
Kalbfleisch, J. Michael ;
Dingess-Hammond, Elizabeth A. ;
Boelke, Andre ;
Weichert, Andreas G. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) :1765-1768
[5]
Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases [J].
Gilmore, Brendan F. ;
Carson, Louise ;
McShane, Laura L. ;
Quinn, Derek ;
Coulter, Wilson A. ;
Walker, Brian .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (01) :373-379
[6]
Synthesis and structure–activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.[J].Hiroshi Fukushima;Akira Hiratate;Masato Takahashi;Masako Saito;Eiji Munetomo;Kiyokazu Kitano;Hidetaka Saito;Yuji Takaoka;Koji Yamamoto.Bioorganic & Medicinal Chemistry.2004, 23
[7]
An aminomethylpyrimidine DPP-IV inhibitor with improved properties [J].
Peters, JU ;
Hunziker, D ;
Fischer, H ;
Kansy, M ;
Weber, S ;
Kritter, S ;
Müller, A ;
Wallier, A ;
Ricklin, F ;
Boehringer, M ;
Poli, SM ;
Csato, M ;
Loeffler, BM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) :3575-3578
[8]
Aminomethylpyrimidines as novel DPP-IV inhibitors:: A 105-fold activity increase by optimization of aromatic substituents [J].
Peters, JU ;
Weber, S ;
Kritter, S ;
Weiss, P ;
Wallier, A ;
Boehringer, M ;
Hennig, M ;
Kuhn, B ;
Loeffler, BM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) :1491-1493
[9]
Metformin and lactic acidosis: cause or coincidence? A review of case reports [J].
Stades, AME ;
Heikens, JT ;
Erkelens, DW ;
Holleman, F ;
Hoekstra, JBL .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (02) :179-187
[10]
Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV [J].
Thoma, R ;
Löffler, B ;
Stihle, M ;
Huber, W ;
Ruf, A ;
Hennig, M .
STRUCTURE, 2003, 11 (08) :947-959